AVO’s goal is to deliver an affordable and novel proton therapy system (PT), based on state-of-the-art technology developed originally at the world-renowned CERN. Achievement of major technical milestones has boosted confidence greatly, and the group remains on track with its strategy. AVO has successfully integrated the four types of structures that constitute the LIGHT accelerator and has overcome technical challenges. The proton beam has been recorded at an energy of 52MeV, sufficient to treat superficial tumours. With the distribution agreement in place for SE Asia, partnerships with both RaySearch and the STFC, and strengthening of its financing structure, AVO is now on a much firmer footing.
If you'd like to be introduced to the team at Advanced Oncotherapy, get in touch.Request a meeting